Beta Bionics (BBNX) Short-term Investments (2023 - 2026)

Beta Bionics' Short-term Investments history runs 4 years deep, the most recent figure standing at $100000.0 for Q1 2026.

• In Q1 2026, Short-term Investments fell 99.95% year-over-year to $100000.0; the TTM figure through Mar 2026 stood at $100000.0 (down 99.95% YoY), while the FY2025 annual figure was $187.5 million, up 156.41% from the prior year.
• Short-term Investments came in at $100000.0 for Q1 2026 at Beta Bionics, down from $187.5 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $214.6 million in Q2 2025 to a low of $100000.0 in Q1 2026.
• A 4-year average of $132.1 million and a median of $187.5 million in 2025 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments jumped 156.41% in 2025 and plunged 99.95% in 2026, its largest moves.
• Beta Bionics' Short-term Investments stood at $70.2 million in 2023, then rose by 4.22% to $73.1 million in 2024, then surged by 156.41% to $187.5 million in 2025, then tumbled by 99.95% to $100000.0 in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $100000.0, $187.5 million, and $190.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison